Provisionally Adopted Major Substantive Rule: Wholesale Prescription Drug Importation Program
Wholesale Prescription Drug Importation Program
Pursuant to P.L. 2019, ch. 472, the major substantive rule provides for a process for the design of a wholesale prescription drug importation program, in anticipation of the release of federal rules establishing an application pathway for demonstration projects allowing importation by states and other entities. It also provides that the Department of Health and Human Services will submit an application under such a pathway on behalf of the State of Maine. This major substantive rule needs Legislative approval before it becomes effective.
Date posted: 1/14/2020